Net profit of Concord Biotech rose 18.17% to Rs 95.74 crore in the quarter ended September 2024 as against Rs 81.02 crore during the previous quarter ended September 2023. Sales rose 18.23% to Rs 310.18 crore in the quarter ended September 2024 as against Rs 262.35 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales310.18262.35 18 OPM %43.1144.11 - PBDT143.65123.00 17 PBT130.34109.70 19 NP95.7481.02 18 Powered by Capital Market - Live News

Concord Biotech will hold a meeting of the Board of Directors of the Company on 11 November 2024Powered by Capital Market - Live News

Net profit of Concord Biotech rose 9.36% to Rs 59.59 crore in the quarter ended June 2024 as against Rs 54.49 crore during the previous quarter ended June 2023. Sales rose 10.76% to Rs 215.80 crore in the quarter ended June 2024 as against Rs 194.83 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales215.80194.83 11 OPM %37.6637.03 - PBDT92.7084.08 10 PBT79.5271.04 12 NP59.5954.49 9 Powered by Capital Market - Live News

Concord Biotech will hold a meeting of the Board of Directors of the Company on 9 August 2024.Powered by Capital Market - Live News

Concord Biotech announced that the 39th Annual General Meeting (AGM) of the company will be held on 29 June 2024.Powered by Capital Market - Live News